Education

Ph.D.  Pharmacy Administration, University of North Carolina at Chapel Hill, 1983
M.S.  Pharmacy Administration, University of North Carolina at Chapel Hill, 1980
B.S.  Pharmacy, University of Maryland, 1976

Background

Richard Schulz, Ph.D., has led a long and distinguished career as a scholar, researcher and exemplary teacher, with 30 years of service on faculty at the College of Pharmacy, following four years at West Virginia University.

Schulz has been extensively involved in teaching undergraduate and graduate courses and mentoring students and junior faculty. He was named Teacher of the Year by the college in 2001 as well as Researcher of the Year in 1999 and 2007. Schulz has more than 30 years of experience as an investigator, examining questions about medication adherence, patient quality of life and the impact of pharmacist interventions. Prior to his academic positions, he was a practicing pharmacist in both hospital and community settings.

Schulz has participated in externally funded field studies that implemented community-based interventions and assessed medication-taking behavior and patient outcomes, including hospitalization and emergency department utilization.  For instance, one of his studies focused on diabetes management in an underserved population. He has collaborated extensively with the Office for the Study of Aging at the Arnold School of Public Health, where he serves as adjunct professor. 

Research Interests

• outcomes research
• medication adherence field and experimental studies
• pharmacoepidemiology
• quality of life
• mental health
• primary data collection methods

Publications

Bennett CL, Chen B, Hermanson T, Wyatt MD, Schulz RM, Georgantopoulos P, Kessler S, Raisch DW, Qureshi ZP, Lu ZK, Love BL, Noxon V, Bobolts L, Armitage M, Bian J, Ray P, Ablin RJ, Hrushesky WJ, Macdougall IC, Sartor O, Armitage JO. Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec;15(13):e594-e605. doi: 10.1016/S1470-2045(14)70365-1. Epub 2014 Nov 24.

Lu ZK, Kessler SJ, Schulz R, Bian J, Chen B., et al.  Systematic Approach to Pharmacovigilance beyond the Limits: The Southern Network on Adverse Reactions (SONAR) Projects. Adv Pharmacoepidemiol Drug Saf, 2014;3:149. doi:10.4172/2167-1052.1000149

Schulz RM, Porter C, Lane M, Cornman A, Branham L.  Impact of a medication management system in nursing home admission rate in a community-dwelling nursing home-eligible Medicaid population. American Journal of Geriatric Pharmacotherapy 2011;9:69-79.

Bookstaver PB, Rudisill CN, Bickley RA, McAbee CE, Miller AD, Piro CC, Schulz R.   Perceived influence of an Evidence Based Medicine elective course on student performance during Advanced Pharmacy Practice Experiences.  Am J Pharm Educ 2011;75(1):Article 9.

Miller AD, Phillips LM, Schulz RM, Bookstaver PB, Rudisill CN.  Differences in hospital glycemic control and insulin requirements recovering from critical illness and those without prior critical illness.  Clinical Pharmacology: Advances and Applications 2010:2;1-6.

Blizzard J, Richardson WH, Michels JE, Reeder CE, Schulz RM, Holstege C.  Cost-Benefit Analysis of a Regional Poison Center.  Clinical Toxicology 2008;46(5):450-6.

SPECTRA Panel Members, Schulz RM, Garnett WR, Bramley T.  Conversions between Monotherapies in Epilepsy: Expert Consensus.  Epilepsy and Behavior 2007;11(2):222-34.

McKeown RE, Cuffe, SP, Schulz RM.  U.S. Suicide Rates by Age Groups, 1970-2002:  An Examination of Recent Trends.  American Journal of Public Health 2006;96(10):1744-51.

---